Pharmacokinetics and tolerability of human mouse chimeric anti-CD22 monoclonal antibody in Chinese patients with CD22-positive non-Hodgkin lymphoma.
about
Generation of anti-idiotype scFv for pharmacokinetic measurement in lymphoma patients treated with chimera anti-CD22 antibody SM03.Surrogate target cells expressing surface anti-idiotype antibody for the clinical evaluation of an internalizing CD22-specific antibody.Challenges and approaches for the development of safer immunomodulatory biologics.Pharmacokinetics, Pharmacodynamics and Preliminary Observations for Clinical Activity and Safety of Multiple Doses of Human Mouse Chimeric Anti-CD22 Monoclonal Antibody (SM03) in Chinese Patients with Systemic Lupus Erythematosus.
P2860
Pharmacokinetics and tolerability of human mouse chimeric anti-CD22 monoclonal antibody in Chinese patients with CD22-positive non-Hodgkin lymphoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Pharmacokinetics and tolerabil ...... positive non-Hodgkin lymphoma.
@ast
Pharmacokinetics and tolerabil ...... positive non-Hodgkin lymphoma.
@en
type
label
Pharmacokinetics and tolerabil ...... positive non-Hodgkin lymphoma.
@ast
Pharmacokinetics and tolerabil ...... positive non-Hodgkin lymphoma.
@en
prefLabel
Pharmacokinetics and tolerabil ...... positive non-Hodgkin lymphoma.
@ast
Pharmacokinetics and tolerabil ...... positive non-Hodgkin lymphoma.
@en
P2093
P2860
P356
P1476
Pharmacokinetics and tolerabil ...... positive non-Hodgkin lymphoma.
@en
P2093
Benyan Zou
Dongsheng Zhang
Liting Deng
Wenqi Jiang
Zhinming Li
P2860
P304
P356
10.4161/MABS.4.2.19136
P577
2012-03-01T00:00:00Z